Chitosan-based intragastric delivery of cefuroxime axetil: Development and in-vitro evaluation of mucoadhesive approach

Artificial Cells, Blood Substitutes, and Biotechnology

Volumn 40, Issue 6, 2012, Pages 406-418

  Nagar, Mitesh ^a   Yadav, Adhikrao V ^b  

^a Govt College of Pharmacy   (India)

^b Gourishankar Institute of Pharmaceutical Education Reseach   (India)

Author keywords

Cefuroxime axetil; Chitosan; Intragastric; Microbeads; Mucoadhesive; Sustained release

Indexed keywords

CEFUROXIME AXETIL; INTRAGASTRIC; MICROBEADS; MUCOADHESIVE; SUSTAINED RELEASE;

BIOCHEMISTRY; DRUG DELIVERY; OPTIMIZATION;

CHITOSAN;

CEFUROXIME AXETIL; CHITOSAN; POLYANION; TRIPOLYPHOSPHATE;

ARTICLE; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG SAFETY; EXPERIMENTAL DESIGN; GELATION; IN VITRO STUDY; MUCOADHESION; RESPONSE SURFACE METHOD;

ADSORPTION; ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BIOLOGICAL AVAILABILITY; CEFUROXIME; CELLS, CULTURED; CHITOSAN; DRUG DELIVERY SYSTEMS; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; GOATS; HUMANS; INTESTINE, SMALL; MICROSPHERES; ORGAN CULTURE TECHNIQUES; POLYPHOSPHATES;

EID: 84875434360     PISSN: 10731199     EISSN: 15324184     Source Type: Journal    
DOI: 10.3109/10731199.2012.696064     Document Type: Article

References (30)

1. nd ed. Boca Raton, FL: Taylor & Francis Group.
2. Bodmeier R, Oh KH, Pramar Y. 1989. Preparation and evaluation of drug-containing chitosan beads. Drug Dev Ind Pharm. 15:9:1475-94.
3. Bonferoni MC, Sandri G, Rossi S, Ferrari F, Caramella C. 2009. Chitosan and its salts for mucosal and transmucosal delivery. Expert Opin Drug Del. 6:9:923-39.
4. British Pharmacopoeia. 2006. Cefuroxime axetil tablet monograph. London: British Pharmacopoeia Commission.
5. Costa P, Lobo JMS. 2001. Modeling and comparison of dissolution prof les. Eur J Pharm Sci. 13:123-33. (Pubitemid 32288781)
6. Dhumal RS, Rajname ST, Dhumal ST, Pawar AP. 2006. Design and evaluation of bilayer f oating tablets of cefuroxime axetil for bimodal release. J Sci Ind Res. 65:812-16. (Pubitemid 44593180)
7. Durkut S, Elcin YM, Elcin EA. 2006. Biodegradation of chitosan-tripolyphosphate beads: In vitro and in vivo studies. Artif cial Cell Blood Subst Biotechnol. 34:263-76.
8. Hari PR, Chandy T, Sharma CP. 1996. Chitosan/calcium alginate microcapsules for intestinal delivery of nitrofurantoin. J Microen-cap. 13:3:319-29. (Pubitemid 26149541)
9. Hejazi R, Amiji M. 2003. Chitosan based gastrointestinal delivery systems. J Control Release. 89:151-65. (Pubitemid 36507012)
10. Huguet ML, Neufeld RJ, Dellacherie E. 1996. Calcium-alginate beads coated with polycationic polymers: Comparison of chitosan and DEAE-dextran. Process Biochem. 31:4:347-53.
11. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. 2003. Stability testing of new drug substances and products Q1A (R2). Current Step 4 version: dated 6 February 2003. Available at: http://www.ich.org/LOB/media/MEDIA419.pdf.
12. James MB, Elliott LG. 1989. Pharmaceutical composition comprising Cefuroxime Axetil, United States Patent 4, 865, 851, September 12, 1989.
13. Jo GH, Yu JH, Yun JH, Hwang SJ, Woo JS. 2002. Preparation of amorphous form of cefuroxime axetil using supercritical f uid processing. Controlled Release Society 29th Annual Meeting Proceedings, Seoul, South Korea, July 20-25, 2002.
14. Lewis GA, Mathieu D, Phan-Tan-Luu R. 1999. Drugs and the pharmaceutical sciences: Pharmaceutical experimental design. New York, Marcel Dekker Inc.
15. Mosher GL, McBee J, Shaw DB. 1992. Esterase activity toward the diastereomers of Cefuroxime Axetil in the rat and dog. Pharm Res. 9:5:687-89.
16. Olivia F, Pierre B, Robert G. 1998. Chitosan: A unique polysaccharide for drug delivery. Drug Dev Ind Pharm. 24:11:979-93.
17. Patel VF, Patel NM. 2006. Intragastric f oating drug delivery system of cefuroxime axetil: In vitro evaluation. AAPS PharmSciTech. 7:1:17:E118-24.
18. Patil DA, Patil GB, Deshmukh PK, Belgamwar VS, Fursule RA. 2009. Chitosan coated mucoadhesive multiparticulate drug delivery system for gliclazide. Asian J Pharm Clin Res. 2:2:62-68.
19. Santus G, Lazzarini C, Bottoni G, Sandefer EP, Page RC, Doll WJ, et al. 1997. An in vitro, in vivo investigation of oral bioadhesive controlled release furosemide formulations. Eur J Pharm Biopharm. 44:39-52. (Pubitemid 28298774)
20. Siepmann J, Peppas NA. 2001. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Del Rev. 48:139-57. (Pubitemid 32434400)
21. Singh B, Ahuja N. 2000. Book review on pharmaceutical experimental design. Int J Pharm. 195:247-48.
22. Singla AK, Chawla M. 2001. Chitosan: Some pharmaceutical and biological aspects-An update. J Pharm Pharmacol. 53:1047-67. (Pubitemid 32754936)
23. Somani JK, Bhushan I, Sen H. 2001. Bioavailable oral dosage form of cefuroxime Axetil, United States Patent 6, 323, 193, November 27, 2001.
24. Somani VG, Shashi SR, Udavant YK, Atram SC, Satpute R, Shinde MN. 2009. A f oating pulsatile drug delivery system based on hollow calcium pectinate beads. Asian J Pharm. 3:120-24.
25. Sommers DK, Wyk MV, Moncrief J, Schoeman HS. 1984. Inf uence of food and reduced gastric acidity on the bioavailability of Bacampi-cillin and Cefuroxime Axetil. Br J Clin Pharmacol. 18:535-39. (Pubitemid 14009946)
26. rd ed. London: The Pharmaceutical Press, 178.
27. Talukder R, Fassihi R. 2004. Gastroretentive delivery systems: A mini review. Drug Dev Ind Pharm. 30:10:1019-28. (Pubitemid 39577994)
28. Woo JS, Chang HC. 2000. Non-crystalline cefuroxime axetil solid dispersant, process for preparing same and composition for oral administration thereof. United States Patent 6, 107, 290. August 22, 2000.
29. Wozniak T, Hicks J. 1991. Cefuroxime sodium. In: Florey K, ed., Analytical Prof les of Drug Substances. San Diego, CA: Academic Press, 209-237.
30. Zhou HY, Guang CX, Zhang W F. 2007. In vitro and in vivo evaluation of mucoadhensiveness of chitosan/cellulose acetate multimicro-spheres. J Biomed Mater Res A. 83:4:1146-53.